McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Dominic J. Caruso DIRECTOR ELECTIONS ISSUER 6735.000000 0 FOR 6735.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Lynne M. Doughtie DIRECTOR ELECTIONS ISSUER 6735.000000 0 FOR 6735.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: W. Roy Dunbar DIRECTOR ELECTIONS ISSUER 6735.000000 0 FOR 6735.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Deborah Dunsire, M.D. DIRECTOR ELECTIONS ISSUER 6735.000000 0 FOR 6735.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Julie L. Gerberding, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 6735.000000 0 FOR 6735.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: James H. Hinton DIRECTOR ELECTIONS ISSUER 6735.000000 0 FOR 6735.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Donald R. Knauss DIRECTOR ELECTIONS ISSUER 6735.000000 0 FOR 6735.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Bradley E. Lerman DIRECTOR ELECTIONS ISSUER 6735.000000 0 FOR 6735.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Maria N. Martinez DIRECTOR ELECTIONS ISSUER 6735.000000 0 FOR 6735.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Kevin M. Ozan DIRECTOR ELECTIONS ISSUER 6735.000000 0 FOR 6735.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Brian S. Tyler DIRECTOR ELECTIONS ISSUER 6735.000000 0 FOR 6735.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Kathleen Wilson-Thompson DIRECTOR ELECTIONS ISSUER 6735.000000 0 FOR 6735.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2026 AUDIT-RELATED ISSUER 6735.000000 0 AGAINST 6735.000000 AGAINST McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Advisory Vote to Approve the Company's Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 6735.000000 0 AGAINST 6735.000000 AGAINST Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Craig Arnold DIRECTOR ELECTIONS ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Scott C. Donnelly DIRECTOR ELECTIONS ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Lidia L. Fonseca DIRECTOR ELECTIONS ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): John P. Groetelaars DIRECTOR ELECTIONS ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Randall J. Hogan, III DIRECTOR ELECTIONS ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): William R. Jellison DIRECTOR ELECTIONS ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Joon S. Lee, M.D. DIRECTOR ELECTIONS ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Gregory P. Lewis DIRECTOR ELECTIONS ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Kevin E. Lofton DIRECTOR ELECTIONS ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Geoffrey S. Martha DIRECTOR ELECTIONS ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Elizabeth G. Nabel, M.D. DIRECTOR ELECTIONS ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Kendall J. Powell DIRECTOR ELECTIONS ISSUER 365043.000000 0 AGAINST 365043.000000 AGAINST Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2026 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration; AUDIT-RELATED ISSUER 365043.000000 0 AGAINST 365043.000000 AGAINST Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Approving, on an advisory basis, the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 365043.000000 0 AGAINST 365043.000000 AGAINST Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Renewing the Board of Directors' authority to issue shares under Irish law; CAPITAL STRUCTURE ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law; CAPITAL STRUCTURE ISSUER 365043.000000 0 AGAINST 365043.000000 AGAINST Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares; CAPITAL STRUCTURE ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Approving an amendment to Article 177 of the Company's Articles of Association, to facilitate the capitalization of certain of the Company's non-distributable reserves; CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Approving a Capital Reduction to Create Distributable Reserves under Irish Law; and CAPITAL STRUCTURE ISSUER 365043.000000 0 FOR 365043.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Approving amendments to the Company's Articles of Association, to update the advance notice provisions. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 365043.000000 0 FOR 365043.000000 FOR I-Mab 44975P103 US44975P1030 10/24/2025 Approve Change of English Name of the Company and Adopt Chinese Name as its New Dual Foreign Name CORPORATE GOVERNANCE ISSUER 43738.000000 0 FOR 43738.000000 FOR I-Mab 44975P103 US44975P1030 10/24/2025 Amend Memorandum and Articles of Association CORPORATE GOVERNANCE ISSUER 43738.000000 0 FOR 43738.000000 FOR ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Carol Burt DIRECTOR ELECTIONS ISSUER 16139.000000 0 FOR 16139.000000 FOR ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Christopher DelOrefice DIRECTOR ELECTIONS ISSUER 16139.000000 0 FOR 16139.000000 FOR ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Jan De Witte DIRECTOR ELECTIONS ISSUER 16139.000000 0 FOR 16139.000000 FOR ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Karen Drexler DIRECTOR ELECTIONS ISSUER 16139.000000 0 FOR 16139.000000 FOR ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Michael Farrell DIRECTOR ELECTIONS ISSUER 16139.000000 0 FOR 16139.000000 FOR ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Peter Farrell DIRECTOR ELECTIONS ISSUER 16139.000000 0 FOR 16139.000000 FOR ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Harjit Gill DIRECTOR ELECTIONS ISSUER 16139.000000 0 FOR 16139.000000 FOR ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: John Hernandez DIRECTOR ELECTIONS ISSUER 16139.000000 0 FOR 16139.000000 FOR ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Nicole Mowad-Nassar DIRECTOR ELECTIONS ISSUER 16139.000000 0 FOR 16139.000000 FOR ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Desney Tan DIRECTOR ELECTIONS ISSUER 16139.000000 0 FOR 16139.000000 FOR ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Ronald Taylor DIRECTOR ELECTIONS ISSUER 16139.000000 0 AGAINST 16139.000000 AGAINST ResMed Inc. 761152107 US7611521078 11/19/2025 Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026. AUDIT-RELATED ISSUER 16139.000000 0 AGAINST 16139.000000 AGAINST ResMed Inc. 761152107 US7611521078 11/19/2025 Approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 16139.000000 0 AGAINST 16139.000000 AGAINST ResMed Inc. 761152107 US7611521078 11/19/2025 Approve the amendment and restatement of our 2009 Incentive Award Plan. COMPENSATION ISSUER 16139.000000 0 FOR 16139.000000 FOR ResMed Inc. 761152107 US7611521078 11/19/2025 Approve the amendment and restatement of our 2018 Employee Stock Purchase Plan. COMPENSATION ISSUER 16139.000000 0 FOR 16139.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: William M. Brown DIRECTOR ELECTIONS ISSUER 115741.000000 0 FOR 115741.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Carrie L. Byington DIRECTOR ELECTIONS ISSUER 115741.000000 0 FOR 115741.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: R. Andrew Eckert DIRECTOR ELECTIONS ISSUER 115741.000000 0 FOR 115741.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Claire M. Fraser DIRECTOR ELECTIONS ISSUER 115741.000000 0 AGAINST 115741.000000 AGAINST Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Gregory J. Hayes DIRECTOR ELECTIONS ISSUER 115741.000000 0 FOR 115741.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Jeffrey W. Henderson DIRECTOR ELECTIONS ISSUER 115741.000000 0 FOR 115741.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Robert L. Huffines DIRECTOR ELECTIONS ISSUER 115741.000000 0 FOR 115741.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Christopher Jones DIRECTOR ELECTIONS ISSUER 115741.000000 0 FOR 115741.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Thomas E. Polen DIRECTOR ELECTIONS ISSUER 115741.000000 0 FOR 115741.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 115741.000000 0 FOR 115741.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Bertram L. Scott DIRECTOR ELECTIONS ISSUER 115741.000000 0 AGAINST 115741.000000 AGAINST Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Joanne Waldstreicher DIRECTOR ELECTIONS ISSUER 115741.000000 0 FOR 115741.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Jacqueline Wright DIRECTOR ELECTIONS ISSUER 115741.000000 0 FOR 115741.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Ratification of the selection of the independent registered public accounting firm AUDIT-RELATED ISSUER 115741.000000 0 AGAINST 115741.000000 AGAINST Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 115741.000000 0 AGAINST 115741.000000 AGAINST Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Approval of an amendment to the 2004 Employee and Director Equity-Based Compensation Plan COMPENSATION ISSUER 115741.000000 0 FOR 115741.000000 FOR Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Raquel C. Bono, M.D. DIRECTOR ELECTIONS ISSUER 48838.000000 0 FOR 48838.000000 FOR Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 48838.000000 0 AGAINST 48838.000000 AGAINST Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: David T. Feinberg, M.D. DIRECTOR ELECTIONS ISSUER 48838.000000 0 FOR 48838.000000 FOR Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Wayne A. I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 48838.000000 0 FOR 48838.000000 FOR Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Kurt J. Hilzinger DIRECTOR ELECTIONS ISSUER 48838.000000 0 AGAINST 48838.000000 AGAINST Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Karen W. Katz DIRECTOR ELECTIONS ISSUER 48838.000000 0 FOR 48838.000000 FOR Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Marcy S. Klevorn DIRECTOR ELECTIONS ISSUER 48838.000000 0 FOR 48838.000000 FOR Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 48838.000000 0 FOR 48838.000000 FOR Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: James A. Rechtin DIRECTOR ELECTIONS ISSUER 48838.000000 0 FOR 48838.000000 FOR Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Gordon Smith DIRECTOR ELECTIONS ISSUER 48838.000000 0 FOR 48838.000000 FOR Humana Inc. 444859102 US4448591028 04/16/2026 The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 48838.000000 0 AGAINST 48838.000000 AGAINST Humana Inc. 444859102 US4448591028 04/16/2026 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 48838.000000 0 AGAINST 48838.000000 AGAINST Humana Inc. 444859102 US4448591028 04/16/2026 The approval of the Humana Inc. 2026 Stock Incentive Plan. COMPENSATION ISSUER 48838.000000 0 FOR 48838.000000 FOR Humana Inc. 444859102 US4448591028 04/16/2026 The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting. COMPENSATION SECURITY HOLDER 48838.000000 0 FOR 48838.000000 AGAINST HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 5667.000000 0 AGAINST 5667.000000 AGAINST HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 5667.000000 0 FOR 5667.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: John W. Chidsey, III DIRECTOR ELECTIONS ISSUER 5667.000000 0 FOR 5667.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 5667.000000 0 FOR 5667.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: William R. Frist DIRECTOR ELECTIONS ISSUER 5667.000000 0 AGAINST 5667.000000 AGAINST HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 5667.000000 0 FOR 5667.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 5667.000000 0 FOR 5667.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Wayne J. Riley, M.D. DIRECTOR ELECTIONS ISSUER 5667.000000 0 FOR 5667.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 5667.000000 0 FOR 5667.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 5667.000000 0 AGAINST 5667.000000 AGAINST HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 5667.000000 0 AGAINST 5667.000000 AGAINST HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. OTHER SOCIAL ISSUES SECURITY HOLDER 5667.000000 0 AGAINST 5667.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding stockholders' right to act by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 5667.000000 0 AGAINST 5667.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): Ari Bousbib DIRECTOR ELECTIONS ISSUER 19723.000000 0 FOR 19723.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): Carol J. Burt DIRECTOR ELECTIONS ISSUER 19723.000000 0 FOR 19723.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): John G. Danhakl DIRECTOR ELECTIONS ISSUER 19723.000000 0 FOR 19723.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): James A. Fasano DIRECTOR ELECTIONS ISSUER 19723.000000 0 FOR 19723.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): Colleen A. Goggins DIRECTOR ELECTIONS ISSUER 19723.000000 0 FOR 19723.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): William G. Kaelin Jr., M.D. DIRECTOR ELECTIONS ISSUER 19723.000000 0 FOR 19723.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): John M. Leonard, M.D. DIRECTOR ELECTIONS ISSUER 19723.000000 0 FOR 19723.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): Leslie Wims Morris DIRECTOR ELECTIONS ISSUER 19723.000000 0 FOR 19723.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): Sheila A. Stamps DIRECTOR ELECTIONS ISSUER 19723.000000 0 FOR 19723.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 19723.000000 0 AGAINST 19723.000000 AGAINST IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 19723.000000 0 AGAINST 19723.000000 AGAINST IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 Approve the adoption of the IQVIA Holdings Inc. 2026 Incentive and Stock Award Plan. COMPENSATION ISSUER 19723.000000 0 AGAINST 19723.000000 AGAINST IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 If properly presented, a stockholder proposal concerning separate Chairman and Chief Executive Officer roles. CORPORATE GOVERNANCE SECURITY HOLDER 19723.000000 0 FOR 19723.000000 AGAINST Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: N. Ahuja DIRECTOR ELECTIONS ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: M. G. O'Grady DIRECTOR ELECTIONS ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 406053.000000 0 AGAINST 406053.000000 AGAINST Abbott Laboratories 002824100 US0028241000 04/24/2026 Approval of the Abbott Laboratories 2026 Incentive Stock Program COMPENSATION ISSUER 406053.000000 0 FOR 406053.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees COMPENSATION ISSUER 406053.000000 0 FOR 406053.000000 FOR Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Robert L. Zerbe DIRECTOR ELECTIONS ISSUER 239509.000000 0 WITHHOLD 239509.000000 AGAINST Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Alan L. Rubino DIRECTOR ELECTIONS ISSUER 239509.000000 0 WITHHOLD 239509.000000 AGAINST Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Heidi Hagen DIRECTOR ELECTIONS ISSUER 239509.000000 0 FOR 239509.000000 FOR Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Kevin F. McLaughlin DIRECTOR ELECTIONS ISSUER 239509.000000 0 FOR 239509.000000 FOR Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Paul K. Wotton DIRECTOR ELECTIONS ISSUER 239509.000000 0 FOR 239509.000000 FOR Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Dominick C. Colangelo DIRECTOR ELECTIONS ISSUER 239509.000000 0 FOR 239509.000000 FOR Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Lisa Wright DIRECTOR ELECTIONS ISSUER 239509.000000 0 FOR 239509.000000 FOR Vericel Corporation 92346J108 US92346J1088 04/29/2026 To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 239509.000000 0 AGAINST 239509.000000 AGAINST Vericel Corporation 92346J108 US92346J1088 04/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 239509.000000 0 AGAINST 239509.000000 AGAINST Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: David C. Habiger DIRECTOR ELECTIONS ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Susan E. Morano DIRECTOR ELECTIONS ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Cheryl Pegus DIRECTOR ELECTIONS ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Cathy R. Smith DIRECTOR ELECTIONS ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Christophe P. Weber DIRECTOR ELECTIONS ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: David S. Wichmann DIRECTOR ELECTIONS ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 238022.000000 0 AGAINST 238022.000000 AGAINST Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 238022.000000 0 AGAINST 238022.000000 AGAINST Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance. COMPENSATION ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation to remove supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders. CORPORATE GOVERNANCE ISSUER 238022.000000 0 FOR 238022.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." CORPORATE GOVERNANCE SECURITY HOLDER 238022.000000 0 FOR 238022.000000 AGAINST Healthpeak Properties, Inc. 42250P103 US42250P1030 04/30/2026 Election of Directors: Scott M. Brinker DIRECTOR ELECTIONS ISSUER 534110.000000 0 FOR 534110.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/30/2026 Election of Directors: Katherine M. Sandstrom DIRECTOR ELECTIONS ISSUER 534110.000000 0 FOR 534110.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/30/2026 Election of Directors: John T. Thomas DIRECTOR ELECTIONS ISSUER 534110.000000 0 FOR 534110.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/30/2026 Election of Directors: Brian G. Cartwright DIRECTOR ELECTIONS ISSUER 534110.000000 0 FOR 534110.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/30/2026 Election of Directors: James B. Connor DIRECTOR ELECTIONS ISSUER 534110.000000 0 FOR 534110.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/30/2026 Election of Directors: R. Kent Griffin, Jr. DIRECTOR ELECTIONS ISSUER 534110.000000 0 FOR 534110.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/30/2026 Election of Directors: Sara G. Lewis DIRECTOR ELECTIONS ISSUER 534110.000000 0 FOR 534110.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/30/2026 Election of Directors: Ava E. Lias-Booker DIRECTOR ELECTIONS ISSUER 534110.000000 0 FOR 534110.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/30/2026 Election of Directors: Richard A. Weiss DIRECTOR ELECTIONS ISSUER 534110.000000 0 FOR 534110.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/30/2026 Approval of 2025 executive compensation on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 534110.000000 0 AGAINST 534110.000000 AGAINST Healthpeak Properties, Inc. 42250P103 US42250P1030 04/30/2026 Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 534110.000000 0 FOR 534110.000000 FOR Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Election of Class II Directors: Gary L. Ellis DIRECTOR ELECTIONS ISSUER 203308.000000 0 WITHHOLD 203308.000000 AGAINST Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Election of Class II Directors: Georgia Melenikiotou DIRECTOR ELECTIONS ISSUER 203308.000000 0 FOR 203308.000000 FOR Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Election of Class II Directors: Dana G. Mead, Jr. DIRECTOR ELECTIONS ISSUER 203308.000000 0 WITHHOLD 203308.000000 AGAINST Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 203308.000000 0 FOR 203308.000000 FOR Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 203308.000000 0 FOR 203308.000000 FOR Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Approval, on a advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 203308.000000 0 ONE YEAR 203308.000000 FOR Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to phase out the classified Board structure and provide for the annual election of all directors beginning with the Company's 2029 annual meeting of stockholders. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 203308.000000 0 FOR 203308.000000 FOR Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. COMPENSATION ISSUER 203308.000000 0 AGAINST 203308.000000 AGAINST Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6. CORPORATE GOVERNANCE ISSUER 203308.000000 0 FOR 203308.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 64078.000000 0 FOR 64078.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 64078.000000 0 FOR 64078.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Lewis Chew DIRECTOR ELECTIONS ISSUER 64078.000000 0 FOR 64078.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 64078.000000 0 AGAINST 64078.000000 AGAINST Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 64078.000000 0 FOR 64078.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 64078.000000 0 FOR 64078.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 64078.000000 0 FOR 64078.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 64078.000000 0 FOR 64078.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 64078.000000 0 FOR 64078.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: David J. Rosa DIRECTOR ELECTIONS ISSUER 64078.000000 0 FOR 64078.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 64078.000000 0 AGAINST 64078.000000 AGAINST Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 64078.000000 0 FOR 64078.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 To approve the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 64078.000000 0 FOR 64078.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term: Carolyn Bertozzi DIRECTOR ELECTIONS ISSUER 31480.000000 0 FOR 31480.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term: William Kaelin, Jr. DIRECTOR ELECTIONS ISSUER 31480.000000 0 FOR 31480.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term: Jon Moeller DIRECTOR ELECTIONS ISSUER 31480.000000 0 FOR 31480.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term: David Ricks DIRECTOR ELECTIONS ISSUER 31480.000000 0 FOR 31480.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 31480.000000 0 FOR 31480.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/04/2026 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026. AUDIT-RELATED ISSUER 31480.000000 0 AGAINST 31480.000000 AGAINST Eli Lilly and Company 532457108 US5324571083 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 31480.000000 0 FOR 31480.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 31480.000000 0 FOR 31480.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/04/2026 Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. CORPORATE GOVERNANCE SECURITY HOLDER 31480.000000 0 FOR 31480.000000 AGAINST Eli Lilly and Company 532457108 US5324571083 05/04/2026 Shareholder proposal to prepare an annual lobbying report. OTHER SOCIAL ISSUES SECURITY HOLDER 31480.000000 0 AGAINST 31480.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 369546.000000 0 FOR 369546.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Deepak L. Bhatt, M.D., M.P.H., M.B.A. DIRECTOR ELECTIONS ISSUER 369546.000000 0 FOR 369546.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Christopher S. Boerner, Ph.D. DIRECTOR ELECTIONS ISSUER 369546.000000 0 FOR 369546.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Julia A. Haller, M.D. DIRECTOR ELECTIONS ISSUER 369546.000000 0 FOR 369546.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Manuel Hidalgo Medina, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 369546.000000 0 FOR 369546.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 369546.000000 0 FOR 369546.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Paula A. Price DIRECTOR ELECTIONS ISSUER 369546.000000 0 FOR 369546.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Derica W. Rice DIRECTOR ELECTIONS ISSUER 369546.000000 0 FOR 369546.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 369546.000000 0 FOR 369546.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Karen H. Vousden, Ph.D. DIRECTOR ELECTIONS ISSUER 369546.000000 0 FOR 369546.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 369546.000000 0 FOR 369546.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 369546.000000 0 AGAINST 369546.000000 AGAINST Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Vote to Approve the Company's 2026 Stock Award and Incentive Plan COMPENSATION ISSUER 369546.000000 0 FOR 369546.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Ratification of the Appointment of an Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 369546.000000 0 AGAINST 369546.000000 AGAINST Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director CORPORATE GOVERNANCE SECURITY HOLDER 369546.000000 0 FOR 369546.000000 AGAINST Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Nancy C. Andrews DIRECTOR ELECTIONS ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Steven Barg DIRECTOR ELECTIONS ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Abraham Ceesay DIRECTOR ELECTIONS ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Mark Enyedy DIRECTOR ELECTIONS ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: James C. Foster DIRECTOR ELECTIONS ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Birgit Girshick DIRECTOR ELECTIONS ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Paul Graves DIRECTOR ELECTIONS ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Reshema Kemps-Polanco DIRECTOR ELECTIONS ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: George Llado DIRECTOR ELECTIONS ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Martin Mackay DIRECTOR ELECTIONS ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Craig B. Thompson DIRECTOR ELECTIONS ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Virginia Wilson DIRECTOR ELECTIONS ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Advisory Approval of 2025 Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 2026 Long-Term Incentive Plan COMPENSATION ISSUER 32984.000000 0 FOR 32984.000000 FOR Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 32984.000000 0 FOR 32984.000000 FOR Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair DIRECTOR ELECTIONS ISSUER 150922.000000 0 FOR 150922.000000 FOR Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan DIRECTOR ELECTIONS ISSUER 150922.000000 0 FOR 150922.000000 FOR Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler DIRECTOR ELECTIONS ISSUER 150922.000000 0 AGAINST 150922.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna DIRECTOR ELECTIONS ISSUER 150922.000000 0 FOR 150922.000000 FOR Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. List DIRECTOR ELECTIONS ISSUER 150922.000000 0 AGAINST 150922.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 150922.000000 0 FOR 150922.000000 FOR Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales DIRECTOR ELECTIONS ISSUER 150922.000000 0 FOR 150922.000000 FOR Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders DIRECTOR ELECTIONS ISSUER 150922.000000 0 AGAINST 150922.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon DIRECTOR ELECTIONS ISSUER 150922.000000 0 AGAINST 150922.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D. DIRECTOR ELECTIONS ISSUER 150922.000000 0 AGAINST 150922.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 150922.000000 0 AGAINST 150922.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/05/2026 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 150922.000000 0 AGAINST 150922.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 150922.000000 0 AGAINST 150922.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/05/2026 To approve the Company's Amended and Restated Omnibus Incentive Plan. COMPENSATION ISSUER 150922.000000 0 FOR 150922.000000 FOR Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Election of Directors: Michael J. Fucci DIRECTOR ELECTIONS ISSUER 335036.000000 0 FOR 335036.000000 FOR Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Election of Directors: Patrice A. Harris, M.D., M.A. DIRECTOR ELECTIONS ISSUER 335036.000000 0 FOR 335036.000000 FOR Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Election of Directors: Daniel J. Cancelmi DIRECTOR ELECTIONS ISSUER 335036.000000 0 FOR 335036.000000 FOR Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. COMPENSATION ISSUER 335036.000000 0 FOR 335036.000000 FOR Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 335036.000000 0 AGAINST 335036.000000 AGAINST Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 335036.000000 0 AGAINST 335036.000000 AGAINST Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Barbara L. Brasier DIRECTOR ELECTIONS ISSUER 55522.000000 0 FOR 55522.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Leo P. Grohowski DIRECTOR ELECTIONS ISSUER 55522.000000 0 FOR 55522.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 55522.000000 0 FOR 55522.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Steven J. Orlando DIRECTOR ELECTIONS ISSUER 55522.000000 0 AGAINST 55522.000000 AGAINST Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Ronna E. Romney DIRECTOR ELECTIONS ISSUER 55522.000000 0 AGAINST 55522.000000 AGAINST Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Richard M. Schapiro DIRECTOR ELECTIONS ISSUER 55522.000000 0 FOR 55522.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Francis S. Soistman DIRECTOR ELECTIONS ISSUER 55522.000000 0 FOR 55522.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Dale B. Wolf DIRECTOR ELECTIONS ISSUER 55522.000000 0 FOR 55522.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Richard C. Zoretic DIRECTOR ELECTIONS ISSUER 55522.000000 0 FOR 55522.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Joseph M. Zubretsky DIRECTOR ELECTIONS ISSUER 55522.000000 0 FOR 55522.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 55522.000000 0 AGAINST 55522.000000 AGAINST Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 55522.000000 0 AGAINST 55522.000000 AGAINST Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To consider and approve an amendment to the Company's 2025 Equity Incentive Plan to increase the number of shares available for issuance under such plan. COMPENSATION ISSUER 55522.000000 0 AGAINST 55522.000000 AGAINST Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To consider and approve an amendment to the Company's Certificate of Incorporation to permit stockholders to call special stockholders meetings. CORPORATE GOVERNANCE ISSUER 55522.000000 0 FOR 55522.000000 FOR Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 21884.000000 0 FOR 21884.000000 FOR Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 21884.000000 0 FOR 21884.000000 FOR Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 21884.000000 0 FOR 21884.000000 FOR Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Emmanuel P. Maceda DIRECTOR ELECTIONS ISSUER 21884.000000 0 FOR 21884.000000 FOR Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 21884.000000 0 FOR 21884.000000 FOR Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Rachel M. Ruggeri DIRECTOR ELECTIONS ISSUER 21884.000000 0 FOR 21884.000000 FOR Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 21884.000000 0 FOR 21884.000000 FOR Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 21884.000000 0 FOR 21884.000000 FOR Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 21884.000000 0 AGAINST 21884.000000 AGAINST Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Rajeev Suri DIRECTOR ELECTIONS ISSUER 21884.000000 0 FOR 21884.000000 FOR Stryker Corporation 863667101 US8636671013 05/06/2026 Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 21884.000000 0 AGAINST 21884.000000 AGAINST Stryker Corporation 863667101 US8636671013 05/06/2026 Advisory Vote to Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 21884.000000 0 AGAINST 21884.000000 AGAINST GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 95461.000000 0 FOR 95461.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: H. Lawrence Culp, Jr. DIRECTOR ELECTIONS ISSUER 95461.000000 0 FOR 95461.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: Rodney F. Hochman DIRECTOR ELECTIONS ISSUER 95461.000000 0 FOR 95461.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: Catherine Lesjak DIRECTOR ELECTIONS ISSUER 95461.000000 0 FOR 95461.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 95461.000000 0 FOR 95461.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: Anne T. Madden DIRECTOR ELECTIONS ISSUER 95461.000000 0 FOR 95461.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: William J. Stromberg DIRECTOR ELECTIONS ISSUER 95461.000000 0 FOR 95461.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: Phoebe L. Yang DIRECTOR ELECTIONS ISSUER 95461.000000 0 FOR 95461.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Approval of our named executive officers' compensation in an advisory vote. SECTION 14A SAY-ON-PAY VOTES ISSUER 95461.000000 0 AGAINST 95461.000000 AGAINST GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent auditor for the fiscal year ending December 31, 2026, AUDIT-RELATED ISSUER 95461.000000 0 FOR 95461.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors: Jennifer L. Davis DIRECTOR ELECTIONS ISSUER 221625.000000 0 FOR 221625.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors: Melody B. Meyer DIRECTOR ELECTIONS ISSUER 221625.000000 0 FOR 221625.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors: Robert A. Michael DIRECTOR ELECTIONS ISSUER 221625.000000 0 FOR 221625.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors: Frederick H. Waddell DIRECTOR ELECTIONS ISSUER 221625.000000 0 FOR 221625.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 221625.000000 0 FOR 221625.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Say on Pay - An advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 221625.000000 0 AGAINST 221625.000000 AGAINST AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting CORPORATE GOVERNANCE ISSUER 221625.000000 0 FOR 221625.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Stockholder Proposal - to Adopt a Policy to Require an Independent Chair CORPORATE GOVERNANCE SECURITY HOLDER 221625.000000 0 FOR 221625.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 60509.000000 0 FOR 60509.000000 FOR Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Consolidated Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 60509.000000 0 FOR 60509.000000 FOR Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Treatment of Losses CAPITAL STRUCTURE ISSUER 60509.000000 0 FOR 60509.000000 FOR Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions CORPORATE GOVERNANCE ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Reelect Sylvie Gregoire as Director DIRECTOR ELECTIONS ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Reelect June Lee as Director DIRECTOR ELECTIONS ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Reelect Troy Ignelzi as Director DIRECTOR ELECTIONS ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Compensation Report COMPENSATION ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Compensation of Sylvie Gregoire, Chairwoman of the Board SECTION 14A SAY-ON-PAY VOTES ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Compensation of Marc de Garidel, CEO SECTION 14A SAY-ON-PAY VOTES ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Compensation Report of Corporate Officers COMPENSATION ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Remuneration Policy of Chairwoman of the Board COMPENSATION ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Remuneration Policy of CEO COMPENSATION ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Remuneration Policy of Directors COMPENSATION ISSUER 60509.000000 0 FOR 60509.000000 FOR Abivax SA 00370M103 US00370M1036 05/11/2026 Authorize Repurchase of Up to 10 Percent of Issued Share Capital CAPITAL STRUCTURE ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Authorize Decrease in Share Capital via Cancellation of Repurchased Shares CAPITAL STRUCTURE ISSUER 60509.000000 0 FOR 60509.000000 FOR Abivax SA 00370M103 US00370M1036 05/11/2026 Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 CAPITAL STRUCTURE ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 CAPITAL STRUCTURE ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 750,000 CAPITAL STRUCTURE ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Issuance of Equity or Equity-Linked Securities for Qualified Investors, up to Aggregate Nominal Amount of EUR 237,873.56 CAPITAL STRUCTURE ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries in the Framework of an Equity Line on the American Market, up to Aggregate Nominal Amount of EUR 20,000 CAPITAL STRUCTURE ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 237,873.56 CAPITAL STRUCTURE ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above CAPITAL STRUCTURE ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Authorize Capitalization of Reserves of Up to EUR 750,000 for Bonus Issue or Increase in Par Value CAPITAL STRUCTURE ISSUER 60509.000000 0 FOR 60509.000000 FOR Abivax SA 00370M103 US00370M1036 05/11/2026 Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind CAPITAL STRUCTURE ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Authorize Capital Increase of Up to EUR 750,000 for Future Exchange Offers CAPITAL STRUCTURE ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Set Total Limit for Capital Increase to Result from Issuance Requests Under Items 17-22 and 25-26 at EUR 750,000 CAPITAL STRUCTURE ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Authorize up to 10 Percent of Issued Capital for Use in Stock Option Plans COMPENSATION ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Approve Issuance of Warrants (Bons) Reserved for Services Providers, Consultants, Employees and Executives, up to 10 Percent of Issued Share Capital COMPENSATION ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Authorize up to 10 Percent of Issued Capital for Use in Restricted Stock Plans COMPENSATION ISSUER 60509.000000 0 AGAINST 60509.000000 AGAINST Abivax SA 00370M103 US00370M1036 05/11/2026 Set Total Limit for Capital Increase to Result from Issuance Requests Under Items 28-30, at 10 Percent of Issued Capital CAPITAL STRUCTURE ISSUER 60509.000000 0 FOR 60509.000000 FOR Abivax SA 00370M103 US00370M1036 05/11/2026 Authorize Capital Issuances for Use in Employee Stock Purchase Plans COMPENSATION ISSUER 60509.000000 0 FOR 60509.000000 FOR Abivax SA 00370M103 US00370M1036 05/11/2026 Authorize Filing of Required Documents/Other Formalities CORPORATE GOVERNANCE ISSUER 60509.000000 0 FOR 60509.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Election of Directors: Gail K. Boudreaux DIRECTOR ELECTIONS ISSUER 52261.000000 0 FOR 52261.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Election of Directors: Robert L. Dixon, Jr. DIRECTOR ELECTIONS ISSUER 52261.000000 0 FOR 52261.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Election of Directors: Deanna D. Strable DIRECTOR ELECTIONS ISSUER 52261.000000 0 FOR 52261.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 52261.000000 0 AGAINST 52261.000000 AGAINST Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Ratification of Ernst & Young LLP as Auditors for 2026. AUDIT-RELATED ISSUER 52261.000000 0 AGAINST 52261.000000 AGAINST Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. OTHER SOCIAL ISSUES SECURITY HOLDER 52261.000000 0 AGAINST 52261.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Approve Treatment of Net Loss CAPITAL STRUCTURE ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Approve Discharge of Board and Senior Management CORPORATE GOVERNANCE ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Reelect Anthony Rosenberg as Director and Board Chair DIRECTOR ELECTIONS ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Reelect Christina Ackermann as Director DIRECTOR ELECTIONS ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Reelect Lionel Carnot as Director DIRECTOR ELECTIONS ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Reelect Arshad Khanani as Director DIRECTOR ELECTIONS ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Reelect Martijn Kleijwegt as Director DIRECTOR ELECTIONS ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Reelect Geraldine O'Keeffe as Director DIRECTOR ELECTIONS ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Reelect Riad Sherif as Director DIRECTOR ELECTIONS ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Reelect Robert Warner as Director DIRECTOR ELECTIONS ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Elect Gregory Perry as Director DIRECTOR ELECTIONS ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Reappoint Lionel Carnot as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Appoint Geraldine O'Keeffe as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Appoint Gregory Perry as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Ratify PricewaterhouseCoopers SA as Statutory Auditors AUDIT-RELATED ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Designate Blum & Partner AG as Independent Proxy CORPORATE GOVERNANCE ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Approve Fixed Remuneration of Directors in the Amount of USD 572,000 COMPENSATION ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Approve Equity-Based Remuneration of Directors in the Amount of USD 2.2 Million COMPENSATION ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Approve Fixed Remuneration of Executive Committee in the Amount of USD 2.5 Million COMPENSATION ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Approve Variable Remuneration of Executive Committee in the Amount of USD 1.8 Million COMPENSATION ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Approve Equity-Based Remuneration of Executive Committee in the Amount of USD 18 Million COMPENSATION ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Approve Remuneration Report (Non-Binding) COMPENSATION ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Approve Creation of Capital Band within the Upper Limit of CHF 930,626.64 and the Lower Limit of CHF 620,417.76 with or without Exclusion of Preemptive Rights CAPITAL STRUCTURE ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Approve Creation of CHF 126,777 Pool of Conditional Capital for Employee Equity Plans COMPENSATION ISSUER 569796.000000 0 FOR 569796.000000 FOR Oculis Holding AG H5870P102 CH1242303498 05/13/2026 Transact Other Business (Voting) CORPORATE GOVERNANCE ISSUER 569796.000000 0 AGAINST 569796.000000 AGAINST Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Election of Directors of Ventas, Inc.: Melody C. Barnes DIRECTOR ELECTIONS ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Election of Directors of Ventas, Inc.: Theodore R. Bigman DIRECTOR ELECTIONS ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Election of Directors of Ventas, Inc.: Debra A. Cafaro DIRECTOR ELECTIONS ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Election of Directors of Ventas, Inc.: Michael J. Embler DIRECTOR ELECTIONS ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Election of Directors of Ventas, Inc.: Matthew J. Lustig DIRECTOR ELECTIONS ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Election of Directors of Ventas, Inc.: Roxanne M. Martino DIRECTOR ELECTIONS ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Election of Directors of Ventas, Inc.: Marguerite M. Nader DIRECTOR ELECTIONS ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Election of Directors of Ventas, Inc.: Sean P. Nolan DIRECTOR ELECTIONS ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Election of Directors of Ventas, Inc.: Walter C. Rakowich DIRECTOR ELECTIONS ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Election of Directors of Ventas, Inc.: Joe V. Rodriguez, Jr. DIRECTOR ELECTIONS ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Election of Directors of Ventas, Inc.: Sumit Roy DIRECTOR ELECTIONS ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Election of Directors of Ventas, Inc.: Maurice S. Smith DIRECTOR ELECTIONS ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Approval, on an advisory basis, of the compensation of named executive officers of Ventas, Inc. SECTION 14A SAY-ON-PAY VOTES ISSUER 121336.000000 0 FOR 121336.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2026 Ratification of the selection of KPMG LLP as independent registered public accounting firm of Ventas, Inc. for fiscal year 2026. AUDIT-RELATED ISSUER 121336.000000 0 FOR 121336.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Fernando Aguirre DIRECTOR ELECTIONS ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Jeffrey R. Balser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: C. David Brown II DIRECTOR ELECTIONS ISSUER 225900.000000 0 AGAINST 225900.000000 AGAINST CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Alecia A. DeCoudreaux DIRECTOR ELECTIONS ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Anne M. Finucane DIRECTOR ELECTIONS ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: John E. Gallina DIRECTOR ELECTIONS ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: J. David Joyner DIRECTOR ELECTIONS ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: J. Scott Kirby DIRECTOR ELECTIONS ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Larry M. Robbins DIRECTOR ELECTIONS ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Douglas H. Shulman DIRECTOR ELECTIONS ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 225900.000000 0 AGAINST 225900.000000 AGAINST CVS Health Corporation 126650100 US1266501006 05/14/2026 Proposal to Approve the Company's 2026 Incentive Compensation Plan. COMPENSATION ISSUER 225900.000000 0 FOR 225900.000000 FOR CVS Health Corporation 126650100 US1266501006 05/14/2026 Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. CORPORATE GOVERNANCE SECURITY HOLDER 225900.000000 0 AGAINST 225900.000000 FOR Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Olivier Loeillot DIRECTOR ELECTIONS ISSUER 54330.000000 0 FOR 54330.000000 FOR Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Karen A. Dawes DIRECTOR ELECTIONS ISSUER 54330.000000 0 AGAINST 54330.000000 AGAINST Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Nicolas M. Barthelemy DIRECTOR ELECTIONS ISSUER 54330.000000 0 FOR 54330.000000 FOR Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Carrie Eglinton Manner DIRECTOR ELECTIONS ISSUER 54330.000000 0 AGAINST 54330.000000 AGAINST Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Konstantin Konstantinov, Ph.D. DIRECTOR ELECTIONS ISSUER 54330.000000 0 FOR 54330.000000 FOR Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Martin D. Madaus, D.V.M., Ph.D. DIRECTOR ELECTIONS ISSUER 54330.000000 0 FOR 54330.000000 FOR Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Rohin Mhatre, Ph.D. DIRECTOR ELECTIONS ISSUER 54330.000000 0 FOR 54330.000000 FOR Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Glenn P. Muir DIRECTOR ELECTIONS ISSUER 54330.000000 0 AGAINST 54330.000000 AGAINST Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Margaret A. Pax DIRECTOR ELECTIONS ISSUER 54330.000000 0 FOR 54330.000000 FOR Repligen Corporation 759916109 US7599161095 05/14/2026 Ratification of the selection of Ernst & Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 54330.000000 0 AGAINST 54330.000000 AGAINST Repligen Corporation 759916109 US7599161095 05/14/2026 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 54330.000000 0 AGAINST 54330.000000 AGAINST Biodesix, Inc. 09075X207 US09075X2071 05/19/2026 To elect the two Class III directors named in this proxy statement to hold office until the 2029 annual meeting of stockholders: Jean Franchi DIRECTOR ELECTIONS ISSUER 394100.000000 0 WITHHOLD 394100.000000 AGAINST Biodesix, Inc. 09075X207 US09075X2071 05/19/2026 To elect the two Class III directors named in this proxy statement to hold office until the 2029 annual meeting of stockholders: Hany Massarany DIRECTOR ELECTIONS ISSUER 394100.000000 0 FOR 394100.000000 FOR Biodesix, Inc. 09075X207 US09075X2071 05/19/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 394100.000000 0 FOR 394100.000000 FOR Biodesix, Inc. 09075X207 US09075X2071 05/19/2026 To approve, on a non-binding advisory basis, the frequency of solicitation of advisory votes to approve named executive officer compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 394100.000000 0 ONE YEAR 394100.000000 FOR Biodesix, Inc. 09075X207 US09075X2071 05/19/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026; AUDIT-RELATED ISSUER 394100.000000 0 FOR 394100.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/19/2026 Election of Directors: Thomas N. Bohjalian DIRECTOR ELECTIONS ISSUER 77778.000000 0 FOR 77778.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/19/2026 Election of Directors: David B. Henry DIRECTOR ELECTIONS ISSUER 77778.000000 0 FOR 77778.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/19/2026 Election of Directors: Constance B. Moore DIRECTOR ELECTIONS ISSUER 77778.000000 0 FOR 77778.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/19/2026 Election of Directors: Glenn Rufrano DIRECTOR ELECTIONS ISSUER 77778.000000 0 FOR 77778.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/19/2026 Election of Directors: Peter A. Scott DIRECTOR ELECTIONS ISSUER 77778.000000 0 FOR 77778.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/19/2026 Election of Directors: Donald C. Wood DIRECTOR ELECTIONS ISSUER 77778.000000 0 FOR 77778.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/19/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2026 fiscal year. AUDIT-RELATED ISSUER 77778.000000 0 FOR 77778.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/19/2026 To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the stockholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2026 Annual Meeting of Stockholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 77778.000000 0 FOR 77778.000000 FOR Insulet Corporation 45784P101 US45784P1012 05/20/2026 Election of Directors: Luciana Borio DIRECTOR ELECTIONS ISSUER 62860.000000 0 FOR 62860.000000 FOR Insulet Corporation 45784P101 US45784P1012 05/20/2026 Election of Directors: Michael R. Minogue DIRECTOR ELECTIONS ISSUER 62860.000000 0 FOR 62860.000000 FOR Insulet Corporation 45784P101 US45784P1012 05/20/2026 Election of Directors: Timothy C. Stonesifer DIRECTOR ELECTIONS ISSUER 62860.000000 0 FOR 62860.000000 FOR Insulet Corporation 45784P101 US45784P1012 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of certain executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 62860.000000 0 AGAINST 62860.000000 AGAINST Insulet Corporation 45784P101 US45784P1012 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 62860.000000 0 FOR 62860.000000 FOR LTC Properties, Inc. 502175102 US5021751020 05/20/2026 Election of Directors: Six directors will be elected to hold office until the 2027 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Cornelia Cheng DIRECTOR ELECTIONS ISSUER 139352.000000 0 FOR 139352.000000 FOR LTC Properties, Inc. 502175102 US5021751020 05/20/2026 Election of Directors: Six directors will be elected to hold office until the 2027 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: David L. Gruber DIRECTOR ELECTIONS ISSUER 139352.000000 0 FOR 139352.000000 FOR LTC Properties, Inc. 502175102 US5021751020 05/20/2026 Election of Directors: Six directors will be elected to hold office until the 2027 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Jeffrey C. Hawken DIRECTOR ELECTIONS ISSUER 139352.000000 0 FOR 139352.000000 FOR LTC Properties, Inc. 502175102 US5021751020 05/20/2026 Election of Directors: Six directors will be elected to hold office until the 2027 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Bradley J. Preber DIRECTOR ELECTIONS ISSUER 139352.000000 0 FOR 139352.000000 FOR LTC Properties, Inc. 502175102 US5021751020 05/20/2026 Election of Directors: Six directors will be elected to hold office until the 2027 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Wendy L. Simpson DIRECTOR ELECTIONS ISSUER 139352.000000 0 FOR 139352.000000 FOR LTC Properties, Inc. 502175102 US5021751020 05/20/2026 Election of Directors: Six directors will be elected to hold office until the 2027 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Timothy J. Triche DIRECTOR ELECTIONS ISSUER 139352.000000 0 AGAINST 139352.000000 AGAINST LTC Properties, Inc. 502175102 US5021751020 05/20/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 139352.000000 0 AGAINST 139352.000000 AGAINST LTC Properties, Inc. 502175102 US5021751020 05/20/2026 Ratification of independent registered public accounting firm. AUDIT-RELATED ISSUER 139352.000000 0 AGAINST 139352.000000 AGAINST Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 258774.000000 0 FOR 258774.000000 FOR Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Sandra Beaver DIRECTOR ELECTIONS ISSUER 258774.000000 0 FOR 258774.000000 FOR Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Myoungil Cha DIRECTOR ELECTIONS ISSUER 258774.000000 0 FOR 258774.000000 FOR Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Peyton Howell DIRECTOR ELECTIONS ISSUER 258774.000000 0 FOR 258774.000000 FOR Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Joao Malagueira DIRECTOR ELECTIONS ISSUER 258774.000000 0 FOR 258774.000000 FOR Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Kathleen McGroddy-Goetz DIRECTOR ELECTIONS ISSUER 258774.000000 0 FOR 258774.000000 FOR Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: John Sheridan DIRECTOR ELECTIONS ISSUER 258774.000000 0 FOR 258774.000000 FOR Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rajwant Sodhi DIRECTOR ELECTIONS ISSUER 258774.000000 0 FOR 258774.000000 FOR Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher Twomey DIRECTOR ELECTIONS ISSUER 258774.000000 0 FOR 258774.000000 FOR Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 258774.000000 0 AGAINST 258774.000000 AGAINST Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To approve the Company's 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares authorized for issuance under the plan. COMPENSATION ISSUER 258774.000000 0 FOR 258774.000000 FOR Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the Delaware General Corporation Law ("DGCL"). CORPORATE GOVERNANCE ISSUER 258774.000000 0 FOR 258774.000000 FOR Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changes based on updates to the DGCL. CORPORATE GOVERNANCE ISSUER 258774.000000 0 FOR 258774.000000 FOR Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 258774.000000 0 FOR 258774.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Marc N. Casper DIRECTOR ELECTIONS ISSUER 55978.000000 0 FOR 55978.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 55978.000000 0 FOR 55978.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 55978.000000 0 FOR 55978.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: C. Martin Harris DIRECTOR ELECTIONS ISSUER 55978.000000 0 FOR 55978.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Tyler Jacks DIRECTOR ELECTIONS ISSUER 55978.000000 0 AGAINST 55978.000000 AGAINST Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 55978.000000 0 FOR 55978.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 55978.000000 0 FOR 55978.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Karen S. Lynch DIRECTOR ELECTIONS ISSUER 55978.000000 0 FOR 55978.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Debora L. Spar DIRECTOR ELECTIONS ISSUER 55978.000000 0 FOR 55978.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 55978.000000 0 AGAINST 55978.000000 AGAINST Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 55978.000000 0 FOR 55978.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 55978.000000 0 AGAINST 55978.000000 AGAINST Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026. AUDIT-RELATED ISSUER 55978.000000 0 AGAINST 55978.000000 AGAINST Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Vanessa Broadhurst DIRECTOR ELECTIONS ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Gavin D.K. Hattersley DIRECTOR ELECTIONS ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Sanjay Khosla DIRECTOR ELECTIONS ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Antoinette R. Leatherberry DIRECTOR ELECTIONS ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Michael B. McCallister DIRECTOR ELECTIONS ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Gregory Norden DIRECTOR ELECTIONS ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Kristin C. Peck DIRECTOR ELECTIONS ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Willie M. Reed DIRECTOR ELECTIONS ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Mark Stetter DIRECTOR ELECTIONS ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Stephanie Tilenius DIRECTOR ELECTIONS ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 189493.000000 0 AGAINST 189493.000000 AGAINST Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Advisory vote to approve the frequency of future advisory votes on our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 189493.000000 0 ONE YEAR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 189493.000000 0 FOR 189493.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Shareholder proposal to permit shareholder action by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 189493.000000 0 AGAINST 189493.000000 FOR NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 1122042.000000 0 FOR 1122042.000000 FOR NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Marjorie C. Green DIRECTOR ELECTIONS ISSUER 1122042.000000 0 FOR 1122042.000000 FOR NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn DIRECTOR ELECTIONS ISSUER 1122042.000000 0 FOR 1122042.000000 FOR NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky DIRECTOR ELECTIONS ISSUER 1122042.000000 0 FOR 1122042.000000 FOR NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 1122042.000000 0 FOR 1122042.000000 FOR NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: John P. Kenny DIRECTOR ELECTIONS ISSUER 1122042.000000 0 FOR 1122042.000000 FOR NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: David B. Perez DIRECTOR ELECTIONS ISSUER 1122042.000000 0 FOR 1122042.000000 FOR NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Felicia Williams DIRECTOR ELECTIONS ISSUER 1122042.000000 0 FOR 1122042.000000 FOR NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Anthony P. Zook DIRECTOR ELECTIONS ISSUER 1122042.000000 0 FOR 1122042.000000 FOR NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1122042.000000 0 AGAINST 1122042.000000 AGAINST NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Approval of the Second Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 1122042.000000 0 FOR 1122042.000000 FOR NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 1122042.000000 0 FOR 1122042.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Dr. Flemming Ornskov, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 10663.000000 0 FOR 10663.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Linda Baddour DIRECTOR ELECTIONS ISSUER 10663.000000 0 FOR 10663.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Udit Batra, Ph.D. DIRECTOR ELECTIONS ISSUER 10663.000000 0 FOR 10663.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Dan Brennan DIRECTOR ELECTIONS ISSUER 10663.000000 0 FOR 10663.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Richard Fearon DIRECTOR ELECTIONS ISSUER 10663.000000 0 FOR 10663.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Claire M. Fraser, Ph.D. DIRECTOR ELECTIONS ISSUER 10663.000000 0 FOR 10663.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Pearl S. Huang, Ph.D. DIRECTOR ELECTIONS ISSUER 10663.000000 0 FOR 10663.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Wei Jiang DIRECTOR ELECTIONS ISSUER 10663.000000 0 FOR 10663.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Heather Knight DIRECTOR ELECTIONS ISSUER 10663.000000 0 FOR 10663.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Christopher A. Kuebler DIRECTOR ELECTIONS ISSUER 10663.000000 0 AGAINST 10663.000000 AGAINST Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Mark Vergnano DIRECTOR ELECTIONS ISSUER 10663.000000 0 FOR 10663.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 10663.000000 0 FOR 10663.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 10663.000000 0 FOR 10663.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/21/2026 Election of Directors: Kenneth J. Bacon DIRECTOR ELECTIONS ISSUER 57915.000000 0 FOR 57915.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/21/2026 Election of Directors: Karen B. DeSalvo DIRECTOR ELECTIONS ISSUER 57915.000000 0 FOR 57915.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/21/2026 Election of Directors: Andrew Gundlach DIRECTOR ELECTIONS ISSUER 57915.000000 0 FOR 57915.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/21/2026 Election of Directors: Dennis G. Lopez DIRECTOR ELECTIONS ISSUER 57915.000000 0 FOR 57915.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/21/2026 Election of Directors: Shankh Mitra DIRECTOR ELECTIONS ISSUER 57915.000000 0 FOR 57915.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/21/2026 Election of Directors: Ade J. Patton DIRECTOR ELECTIONS ISSUER 57915.000000 0 FOR 57915.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/21/2026 Election of Directors: Sergio D. Rivera DIRECTOR ELECTIONS ISSUER 57915.000000 0 FOR 57915.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/21/2026 Election of Directors: Johnese M. Spisso DIRECTOR ELECTIONS ISSUER 57915.000000 0 FOR 57915.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/21/2026 Election of Directors: Kathryn M. Sullivan DIRECTOR ELECTIONS ISSUER 57915.000000 0 FOR 57915.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/21/2026 The ratification of the selection of Ernst & Young LLP as Welltower Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 57915.000000 0 AGAINST 57915.000000 AGAINST Welltower Inc. 95040Q104 US95040Q1040 05/21/2026 The approval, on an advisory basis, of the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 57915.000000 0 AGAINST 57915.000000 AGAINST Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 417254.000000 0 FOR 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 417254.000000 0 FOR 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 417254.000000 0 FOR 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Robert M. Davis DIRECTOR ELECTIONS ISSUER 417254.000000 0 FOR 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 417254.000000 0 AGAINST 417254.000000 AGAINST Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Surendralal L. Karsanbhai DIRECTOR ELECTIONS ISSUER 417254.000000 0 FOR 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 417254.000000 0 FOR 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 417254.000000 0 FOR 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 417254.000000 0 FOR 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Patricia F. Russo DIRECTOR ELECTIONS ISSUER 417254.000000 0 AGAINST 417254.000000 AGAINST Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 417254.000000 0 FOR 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 417254.000000 0 FOR 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 417254.000000 0 FOR 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 417254.000000 0 AGAINST 417254.000000 AGAINST Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Ratification of the appointment of the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 417254.000000 0 AGAINST 417254.000000 AGAINST Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on DEI risks in federal contracting. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 417254.000000 0 AGAINST 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on healthcare coverage gaps. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 417254.000000 0 AGAINST 417254.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on political contributions. OTHER SOCIAL ISSUES SECURITY HOLDER 417254.000000 0 AGAINST 417254.000000 FOR Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D. DIRECTOR ELECTIONS ISSUER 65097.000000 0 FOR 65097.000000 FOR Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 Election of Class I Directors for terms expiring in 2029: Wendell Wierenga, Ph.D. DIRECTOR ELECTIONS ISSUER 65097.000000 0 FOR 65097.000000 FOR Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 Election of Class I Directors for terms expiring in 2029: Nancy J. Wysenski DIRECTOR ELECTIONS ISSUER 65097.000000 0 FOR 65097.000000 FOR Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock. COMPENSATION ISSUER 65097.000000 0 FOR 65097.000000 FOR Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 65097.000000 0 FOR 65097.000000 FOR Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 65097.000000 0 FOR 65097.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Steven Altman DIRECTOR ELECTIONS ISSUER 87236.000000 0 FOR 87236.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Dr. Euan Ashley DIRECTOR ELECTIONS ISSUER 87236.000000 0 FOR 87236.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Nicholas Augustinos DIRECTOR ELECTIONS ISSUER 87236.000000 0 AGAINST 87236.000000 AGAINST DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Richard Collins DIRECTOR ELECTIONS ISSUER 87236.000000 0 FOR 87236.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rimma Driscoll DIRECTOR ELECTIONS ISSUER 87236.000000 0 FOR 87236.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Mark Foletta DIRECTOR ELECTIONS ISSUER 87236.000000 0 FOR 87236.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Renee Gala DIRECTOR ELECTIONS ISSUER 87236.000000 0 FOR 87236.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Bridgette Heller DIRECTOR ELECTIONS ISSUER 87236.000000 0 FOR 87236.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Jacob Leach DIRECTOR ELECTIONS ISSUER 87236.000000 0 FOR 87236.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kyle Malady DIRECTOR ELECTIONS ISSUER 87236.000000 0 FOR 87236.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rick Osterloh DIRECTOR ELECTIONS ISSUER 87236.000000 0 FOR 87236.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kevin Sayer DIRECTOR ELECTIONS ISSUER 87236.000000 0 FOR 87236.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To ratify the selection by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 87236.000000 0 FOR 87236.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 87236.000000 0 AGAINST 87236.000000 AGAINST National Health Investors, Inc. 63633D104 US63633D1046 05/27/2026 Election of Directors: Robert W. Chapin, Jr. DIRECTOR ELECTIONS ISSUER 5596.000000 0 FOR 5596.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/27/2026 Election of Directors: Tracy M.J. Colden DIRECTOR ELECTIONS ISSUER 5596.000000 0 FOR 5596.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/27/2026 Election of Directors: Lilly H. Donohue DIRECTOR ELECTIONS ISSUER 5596.000000 0 FOR 5596.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/27/2026 Election of Directors: James R. Jobe DIRECTOR ELECTIONS ISSUER 5596.000000 0 FOR 5596.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/27/2026 Election of Directors: Robert A. McCabe, Jr. DIRECTOR ELECTIONS ISSUER 5596.000000 0 AGAINST 5596.000000 AGAINST National Health Investors, Inc. 63633D104 US63633D1046 05/27/2026 Election of Directors: D. Eric Mendelsohn DIRECTOR ELECTIONS ISSUER 5596.000000 0 FOR 5596.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/27/2026 Election of Directors: Candice W. Todd DIRECTOR ELECTIONS ISSUER 5596.000000 0 FOR 5596.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/27/2026 Approve, on a non-binding advisory basis, the compensation paid to our named executive officers as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 5596.000000 0 FOR 5596.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/27/2026 Ratify the audit committee's selection of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 5596.000000 0 AGAINST 5596.000000 AGAINST Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Saumya Sutaria DIRECTOR ELECTIONS ISSUER 12587.000000 0 FOR 12587.000000 FOR Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: J. Robert Kerrey DIRECTOR ELECTIONS ISSUER 12587.000000 0 AGAINST 12587.000000 AGAINST Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Vineeta Agarwala DIRECTOR ELECTIONS ISSUER 12587.000000 0 FOR 12587.000000 FOR Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: James L. Bierman DIRECTOR ELECTIONS ISSUER 12587.000000 0 FOR 12587.000000 FOR Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Roy Blunt DIRECTOR ELECTIONS ISSUER 12587.000000 0 FOR 12587.000000 FOR Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Richard W. Fisher DIRECTOR ELECTIONS ISSUER 12587.000000 0 FOR 12587.000000 FOR Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Meghan M. FitzGerald DIRECTOR ELECTIONS ISSUER 12587.000000 0 FOR 12587.000000 FOR Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Cecil D. Haney DIRECTOR ELECTIONS ISSUER 12587.000000 0 FOR 12587.000000 FOR Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Christopher S. Lynch DIRECTOR ELECTIONS ISSUER 12587.000000 0 FOR 12587.000000 FOR Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Richard J. Mark DIRECTOR ELECTIONS ISSUER 12587.000000 0 FOR 12587.000000 FOR Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Tammy Romo DIRECTOR ELECTIONS ISSUER 12587.000000 0 FOR 12587.000000 FOR Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Nadja Y. West DIRECTOR ELECTIONS ISSUER 12587.000000 0 FOR 12587.000000 FOR Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To vote, on an advisory basis, to approve the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 12587.000000 0 AGAINST 12587.000000 AGAINST Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accountants for the year ending December 31, 2026. AUDIT-RELATED ISSUER 12587.000000 0 FOR 12587.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Charles Baker DIRECTOR ELECTIONS ISSUER 37141.000000 0 FOR 37141.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Timothy Flynn DIRECTOR ELECTIONS ISSUER 37141.000000 0 FOR 37141.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Paul Garcia DIRECTOR ELECTIONS ISSUER 37141.000000 0 FOR 37141.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Kristen Gil DIRECTOR ELECTIONS ISSUER 37141.000000 0 FOR 37141.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 37141.000000 0 FOR 37141.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Stephen Hemsley DIRECTOR ELECTIONS ISSUER 37141.000000 0 FOR 37141.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: F. William McNabb III DIRECTOR ELECTIONS ISSUER 37141.000000 0 FOR 37141.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 37141.000000 0 FOR 37141.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 37141.000000 0 FOR 37141.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 37141.000000 0 AGAINST 37141.000000 AGAINST UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 37141.000000 0 AGAINST 37141.000000 AGAINST UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. CORPORATE GOVERNANCE SECURITY HOLDER 37141.000000 0 AGAINST 37141.000000 FOR InspireMD, Inc. 45779A846 US45779A8466 06/03/2026 Election of three Class III directors to serve on the Company's board of directors for a term of three years or until his successor is elected and qualified: Marvin Slosman DIRECTOR ELECTIONS ISSUER 1059385.000000 0 FOR 1059385.000000 FOR InspireMD, Inc. 45779A846 US45779A8466 06/03/2026 Election of three Class III directors to serve on the Company's board of directors for a term of three years or until his successor is elected and qualified: Raymond Cohen DIRECTOR ELECTIONS ISSUER 1059385.000000 0 WITHHOLD 1059385.000000 AGAINST InspireMD, Inc. 45779A846 US45779A8466 06/03/2026 Election of three Class III directors to serve on the Company's board of directors for a term of three years or until his successor is elected and qualified: Dan Dearen DIRECTOR ELECTIONS ISSUER 1059385.000000 0 WITHHOLD 1059385.000000 AGAINST InspireMD, Inc. 45779A846 US45779A8466 06/03/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the authorized shares of common stock from 150,000,000 to 250,000,000. CAPITAL STRUCTURE ISSUER 1059385.000000 0 FOR 1059385.000000 FOR InspireMD, Inc. 45779A846 US45779A8466 06/03/2026 Ratification of the appointment of Kesselman & Kesselman, Certified Public Accountants, a member of PricewaterhouseCoopers International Limited, as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1059385.000000 0 FOR 1059385.000000 FOR InspireMD, Inc. 45779A846 US45779A8466 06/03/2026 To approve an adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes to establish a quorum or in favor of proposals 1 through 3. CORPORATE GOVERNANCE ISSUER 1059385.000000 0 FOR 1059385.000000 FOR Alignment Healthcare, Inc. 01625V104 US01625V1044 06/04/2026 Election of Directors: Jody Bilney DIRECTOR ELECTIONS ISSUER 413043.000000 0 WITHHOLD 413043.000000 AGAINST Alignment Healthcare, Inc. 01625V104 US01625V1044 06/04/2026 Election of Directors: David Hodgson DIRECTOR ELECTIONS ISSUER 413043.000000 0 WITHHOLD 413043.000000 AGAINST Alignment Healthcare, Inc. 01625V104 US01625V1044 06/04/2026 Election of Directors: Jacqueline Kosecoff DIRECTOR ELECTIONS ISSUER 413043.000000 0 WITHHOLD 413043.000000 AGAINST Alignment Healthcare, Inc. 01625V104 US01625V1044 06/04/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 413043.000000 0 FOR 413043.000000 FOR Alignment Healthcare, Inc. 01625V104 US01625V1044 06/04/2026 Approval, on an non-binding, advisory basis, of the compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 413043.000000 0 FOR 413043.000000 FOR Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 1110404.000000 0 FOR 1110404.000000 FOR Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Rashmi Kumar DIRECTOR ELECTIONS ISSUER 1110404.000000 0 FOR 1110404.000000 FOR Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Lee N. Newcomer, M.D. DIRECTOR ELECTIONS ISSUER 1110404.000000 0 FOR 1110404.000000 FOR Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1110404.000000 0 AGAINST 1110404.000000 AGAINST Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1110404.000000 0 AGAINST 1110404.000000 AGAINST Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 To approve the proposed amendment to the Amended and Restated 2012 Employee Stock Purchase Plan. COMPENSATION ISSUER 1110404.000000 0 FOR 1110404.000000 FOR Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 To approve the proposed 2026 Employee, Director and Consultant Equity Incentive Plan. COMPENSATION ISSUER 1110404.000000 0 FOR 1110404.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 961017.000000 0 FOR 961017.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Hans Wigzell, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 961017.000000 0 FOR 961017.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Kathryn J. Boor, Ph.D. DIRECTOR ELECTIONS ISSUER 961017.000000 0 FOR 961017.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Michael Chambers DIRECTOR ELECTIONS ISSUER 961017.000000 0 FOR 961017.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Deirdre Connelly DIRECTOR ELECTIONS ISSUER 961017.000000 0 FOR 961017.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 Advisory vote to approve, on a non-binding basis, named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 961017.000000 0 AGAINST 961017.000000 AGAINST Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 Approve the Company's 2026 Equity Incentive Plan COMPENSATION ISSUER 961017.000000 0 FOR 961017.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 Approve the Company's 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 961017.000000 0 FOR 961017.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2026 AUDIT-RELATED ISSUER 961017.000000 0 FOR 961017.000000 FOR Sera Prognostics, Inc. 81749D107 US81749D1072 06/04/2026 Election of Directors: Kim Kamdar, Ph.D. DIRECTOR ELECTIONS ISSUER 1254982.000000 0 WITHHOLD 1254982.000000 AGAINST Sera Prognostics, Inc. 81749D107 US81749D1072 06/04/2026 Election of Directors: Sandra A.J. Lawrence DIRECTOR ELECTIONS ISSUER 1254982.000000 0 FOR 1254982.000000 FOR Sera Prognostics, Inc. 81749D107 US81749D1072 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1254982.000000 0 FOR 1254982.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/05/2026 Election of Directors: Kapila K. Anand DIRECTOR ELECTIONS ISSUER 297889.000000 0 FOR 297889.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/05/2026 Election of Directors: Craig R. Callen DIRECTOR ELECTIONS ISSUER 297889.000000 0 FOR 297889.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/05/2026 Election of Directors: Dr. Lisa C. Egbuonu-Davis DIRECTOR ELECTIONS ISSUER 297889.000000 0 FOR 297889.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/05/2026 Election of Directors: Barbara B. Hill DIRECTOR ELECTIONS ISSUER 297889.000000 0 AGAINST 297889.000000 AGAINST Omega Healthcare Investors, Inc. 681936100 US6819361006 06/05/2026 Election of Directors: Kevin J. Jacobs DIRECTOR ELECTIONS ISSUER 297889.000000 0 FOR 297889.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/05/2026 Election of Directors: C. Taylor Pickett DIRECTOR ELECTIONS ISSUER 297889.000000 0 FOR 297889.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/05/2026 Election of Directors: Stephen D. Plavin DIRECTOR ELECTIONS ISSUER 297889.000000 0 AGAINST 297889.000000 AGAINST Omega Healthcare Investors, Inc. 681936100 US6819361006 06/05/2026 Election of Directors: Burke W. Whitman DIRECTOR ELECTIONS ISSUER 297889.000000 0 FOR 297889.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/05/2026 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for year ending December 31, 2026 AUDIT-RELATED ISSUER 297889.000000 0 AGAINST 297889.000000 AGAINST Omega Healthcare Investors, Inc. 681936100 US6819361006 06/05/2026 Approval, on an advisory basis, of the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 297889.000000 0 FOR 297889.000000 FOR Diversified Healthcare Trust 25525P107 US25525P1075 06/10/2026 Election of Trustees. Nominees (for Independent Trustee): Alan Felder DIRECTOR ELECTIONS ISSUER 293879.000000 0 FOR 293879.000000 FOR Diversified Healthcare Trust 25525P107 US25525P1075 06/10/2026 Election of Trustees. Nominees (for Independent Trustee): Lisa Harris Jones DIRECTOR ELECTIONS ISSUER 293879.000000 0 WITHHOLD 293879.000000 AGAINST Diversified Healthcare Trust 25525P107 US25525P1075 06/10/2026 Election of Trustees. Nominees (for Independent Trustee): Phyllis M. Hollis DIRECTOR ELECTIONS ISSUER 293879.000000 0 FOR 293879.000000 FOR Diversified Healthcare Trust 25525P107 US25525P1075 06/10/2026 Election of Trustees. Nominees (for Independent Trustee): Dawn K. Neher DIRECTOR ELECTIONS ISSUER 293879.000000 0 FOR 293879.000000 FOR Diversified Healthcare Trust 25525P107 US25525P1075 06/10/2026 Election of Trustees. Nominees (for Independent Trustee): Jeffrey P. Somers DIRECTOR ELECTIONS ISSUER 293879.000000 0 WITHHOLD 293879.000000 AGAINST Diversified Healthcare Trust 25525P107 US25525P1075 06/10/2026 Election of Trustees. Nominees (for Managing Trustee): Christopher J. Bilotto DIRECTOR ELECTIONS ISSUER 293879.000000 0 FOR 293879.000000 FOR Diversified Healthcare Trust 25525P107 US25525P1075 06/10/2026 Election of Trustees. Nominees (for Managing Trustee): Adam Portnoy DIRECTOR ELECTIONS ISSUER 293879.000000 0 WITHHOLD 293879.000000 AGAINST Diversified Healthcare Trust 25525P107 US25525P1075 06/10/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 293879.000000 0 AGAINST 293879.000000 AGAINST Diversified Healthcare Trust 25525P107 US25525P1075 06/10/2026 Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2026 fiscal year. AUDIT-RELATED ISSUER 293879.000000 0 FOR 293879.000000 FOR Perceptive Capital Solutions Corp. 35661P100 US35661P1003 06/10/2026 The Extension Amendment Proposal - RESOLVED, as a special resolution that: a) Article 38.8 of PCSC's Amended and Restated Memorandum and Articles of Association be deleted in its entirety and replaced with the following new Article 38.8: "In the event that the Company does not consummate a Business Combination by June 13, 2027, such earlier time as the directors may approve or such later time as the Members of the Company may approve in accordance with the Articles (in any case, such date being referred to as the "Termination Date"), the Company shall: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company for Permitted Withdrawals (less up to US$100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Public Shares in issue, which redemption will completely extinguish public Members' rights as Members (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company's remaining Members and the directors, liquidate and dissolve, subject in the case of sub-articles (ii) and (iii), to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of Applicable Law. If the Company shall wind up for any other reason prior to the consummation of a Business Combination, the Company shall, as promptly as reasonably possible but not more than ten business days thereafter, follow the foregoing procedures set out in this Article 38.8 with respect to the liquidation of the Trust Account, subject to its obligations under Cayman Islands law to provide for claims of creditors and subject to the other requirements of Applicable Law." b) Article 38.9 of PCSC's Amended and Restated Memorandum and Articles of Association be deleted in its entirety and replaced with the following new Article 38.9: In the event that any amendment is made to these Articles: (a) that would modify the substance or timing of the Company's obligation to provide holders of Public Shares the right to: (i) have their shares redeemed or repurchased in connection with a Business Combination pursuant to Articles 38.2(b) or 38.6; or (ii) redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within thirty-six (36) months after the date of the closing of the IPO pursuant to Article 38.8; or (b) with respect to any other provision relating to the rights of holders of Public Shares, each holder of Public Shares who is not a Founder, officer or director shall be provided with the opportunity to redeem their Public Shares following the approval, and upon the implementation by the directors, of any such amendment (an Amendment Redemption) at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less Permitted Withdrawals), divided by the number of then-outstanding Public Shares in issue." CORPORATE GOVERNANCE ISSUER 355447.000000 0 FOR 355447.000000 FOR Perceptive Capital Solutions Corp. 35661P100 US35661P1003 06/10/2026 The Adjournment Proposal - RESOLVED, as an ordinary resolution, that the adjournment of the Shareholder Meeting to a later date or dates if necessary, (i) to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Shareholder Meeting, there are insufficient Class A ordinary shares, par value $0.0001 per share (the "Public Shares") and Class B ordinary shares, par value $0.0001 per share in the capital of PCSC represented (either in person or by proxy) to approve the Extension Amendment Proposal, or (ii) if the holders of Public Shares have elected to redeem an amount of shares in connection with the Extension Amendment Proposal such that PCSC would not adhere to the continued listing requirements of the Nasdaq Stock Market LLC CORPORATE GOVERNANCE ISSUER 355447.000000 0 FOR 355447.000000 FOR Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/10/2026 To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory Norden DIRECTOR ELECTIONS ISSUER 44768.000000 0 FOR 44768.000000 FOR Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/10/2026 To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Marcio Souza DIRECTOR ELECTIONS ISSUER 44768.000000 0 FOR 44768.000000 FOR Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/10/2026 To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young DIRECTOR ELECTIONS ISSUER 44768.000000 0 WITHHOLD 44768.000000 AGAINST Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/10/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 44768.000000 0 FOR 44768.000000 FOR Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/10/2026 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 44768.000000 0 FOR 44768.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Adoption of the 2025 Dutch statutory annual accounts for the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Discharge of liability of the members of the Board for their management during the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Reappointment of Madhavan Balachandran as non-executive director. DIRECTOR ELECTIONS ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Reappointment of Jack Kaye as non-executive director. DIRECTOR ELECTIONS ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Reappointment of Leonard Post, Ph.D. as non-executive director. DIRECTOR ELECTIONS ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Designation of the Board as the competent body to issue Ordinary Shares and grant rights to subscribe for Ordinary Shares. CAPITAL STRUCTURE ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Designation of the Board as the competent body to exclude or limit preemptive rights upon the issuance of Ordinary Shares. CAPITAL STRUCTURE ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Reauthorization of the Board to repurchase Ordinary Shares. CAPITAL STRUCTURE ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Appointment of KPMG Accountants N.V. as external auditor of the Company for the fiscal year 2026. AUDIT-RELATED ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Approval, on an advisory basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Approval, on an advisory basis, of the frequency of advisory votes on the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 966847.000000 0 ONE YEAR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Resolution to adopt the Amendment and Restatement of the 2014 Share Incentive Plan. COMPENSATION ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Resolution to adopt the amendment to the Articles of Association to reflect Dutch large company regime. CORPORATE GOVERNANCE ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Resolution to adopt the amendment to the Articles of Association to increase the authorized share capital and number of Ordinary Shares. CAPITAL STRUCTURE ISSUER 966847.000000 0 FOR 966847.000000 FOR uniQure N.V. N90064101 NL0010696654 06/10/2026 Resolution to adopt the amendment to the Articles of Association to include a federal forum selection provision. SHAREHOLDER RIGHTS AND DEFENSES CORPORATE GOVERNANCE ISSUER 966847.000000 0 FOR 966847.000000 FOR Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 Election of Directors: Dietmar Berger, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 266041.000000 0 WITHHOLD 266041.000000 AGAINST Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 Election of Directors: David Lacey, M.D. DIRECTOR ELECTIONS ISSUER 266041.000000 0 WITHHOLD 266041.000000 AGAINST Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 Election of Directors: Nicole Lambert DIRECTOR ELECTIONS ISSUER 266041.000000 0 WITHHOLD 266041.000000 AGAINST Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 Election of Directors: Johanna Mercier DIRECTOR ELECTIONS ISSUER 266041.000000 0 WITHHOLD 266041.000000 AGAINST Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 266041.000000 0 FOR 266041.000000 FOR Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 266041.000000 0 AGAINST 266041.000000 AGAINST BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Theresa M. Heggie DIRECTOR ELECTIONS ISSUER 1960732.000000 0 FOR 1960732.000000 FOR BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Amy E. Mckee, M.D. DIRECTOR ELECTIONS ISSUER 1960732.000000 0 FOR 1960732.000000 FOR BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Jon P. Stonehouse DIRECTOR ELECTIONS ISSUER 1960732.000000 0 FOR 1960732.000000 FOR BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026. AUDIT-RELATED ISSUER 1960732.000000 0 FOR 1960732.000000 FOR BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 To hold a non-binding, advisory vote regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1960732.000000 0 FOR 1960732.000000 FOR BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. COMPENSATION ISSUER 1960732.000000 0 FOR 1960732.000000 FOR CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Election of Directors: Fred E. Cohen, M.D., D. Phil DIRECTOR ELECTIONS ISSUER 249222.000000 0 WITHHOLD 249222.000000 AGAINST CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Election of Directors: R. Bryan Riggsbee DIRECTOR ELECTIONS ISSUER 249222.000000 0 FOR 249222.000000 FOR CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Election of Directors: Suresh Gunasekaran DIRECTOR ELECTIONS ISSUER 249222.000000 0 FOR 249222.000000 FOR CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Election of Directors: Michael D. Goldberg DIRECTOR ELECTIONS ISSUER 249222.000000 0 FOR 249222.000000 FOR CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Election of Directors: John W. Hanna DIRECTOR ELECTIONS ISSUER 249222.000000 0 FOR 249222.000000 FOR CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 249222.000000 0 FOR 249222.000000 FOR CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 249222.000000 0 FOR 249222.000000 FOR CareDx, Inc. 14167L103 US14167L1035 06/11/2026 To vote, on an advisory basis, the frequency of advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 249222.000000 0 ONE YEAR 249222.000000 FOR CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Approval of an amendment to the 2024 Equity Incentive Plan. COMPENSATION ISSUER 249222.000000 0 FOR 249222.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: Joseph L. Goldstein, M.D. DIRECTOR ELECTIONS ISSUER 6564.000000 0 AGAINST 6564.000000 AGAINST Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: Christine A. Poon DIRECTOR ELECTIONS ISSUER 6564.000000 0 AGAINST 6564.000000 AGAINST Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: David P. Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 6564.000000 0 FOR 6564.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: Craig B. Thompson, M.D. DIRECTOR ELECTIONS ISSUER 6564.000000 0 AGAINST 6564.000000 AGAINST Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: Huda Y. Zoghbi, M.D. DIRECTOR ELECTIONS ISSUER 6564.000000 0 FOR 6564.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 6564.000000 0 FOR 6564.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Proposal to approve, on an advisory basis, compensation of the Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 6564.000000 0 FOR 6564.000000 FOR Vaxcyte, Inc. 92243G108 US92243G1085 06/15/2026 Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Olivier Brandicourt, M.D. DIRECTOR ELECTIONS ISSUER 54750.000000 0 WITHHOLD 54750.000000 AGAINST Vaxcyte, Inc. 92243G108 US92243G1085 06/15/2026 Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Halley Gilbert, J.D. DIRECTOR ELECTIONS ISSUER 54750.000000 0 WITHHOLD 54750.000000 AGAINST Vaxcyte, Inc. 92243G108 US92243G1085 06/15/2026 Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Grant E. Pickering, M.B.A. DIRECTOR ELECTIONS ISSUER 54750.000000 0 FOR 54750.000000 FOR Vaxcyte, Inc. 92243G108 US92243G1085 06/15/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 54750.000000 0 FOR 54750.000000 FOR Vaxcyte, Inc. 92243G108 US92243G1085 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 54750.000000 0 FOR 54750.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/17/2026 Election of Directors: Craig A. Barbarosh DIRECTOR ELECTIONS ISSUER 530480.000000 0 AGAINST 530480.000000 AGAINST Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/17/2026 Election of Directors: Katie Cusack DIRECTOR ELECTIONS ISSUER 530480.000000 0 FOR 530480.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/17/2026 Election of Directors: Michael J. Foster DIRECTOR ELECTIONS ISSUER 530480.000000 0 AGAINST 530480.000000 AGAINST Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/17/2026 Election of Directors: Lynne S. Katzmann DIRECTOR ELECTIONS ISSUER 530480.000000 0 FOR 530480.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/17/2026 Election of Directors: Ann Kono DIRECTOR ELECTIONS ISSUER 530480.000000 0 FOR 530480.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/17/2026 Election of Directors: Jeffrey A. Malehorn DIRECTOR ELECTIONS ISSUER 530480.000000 0 FOR 530480.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/17/2026 Election of Directors: Richard K. Matros DIRECTOR ELECTIONS ISSUER 530480.000000 0 FOR 530480.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/17/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 530480.000000 0 FOR 530480.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/17/2026 Approval, on an advisory basis, of the compensation of Sabra's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 530480.000000 0 AGAINST 530480.000000 AGAINST Disc Medicine, Inc. 254604101 US2546041011 06/18/2026 To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D. DIRECTOR ELECTIONS ISSUER 86107.000000 0 WITHHOLD 86107.000000 AGAINST Disc Medicine, Inc. 254604101 US2546041011 06/18/2026 To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: John Quisel, J.D., Ph.D. DIRECTOR ELECTIONS ISSUER 86107.000000 0 FOR 86107.000000 FOR Disc Medicine, Inc. 254604101 US2546041011 06/18/2026 To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: William White, M.P.P., J.D. DIRECTOR ELECTIONS ISSUER 86107.000000 0 FOR 86107.000000 FOR Disc Medicine, Inc. 254604101 US2546041011 06/18/2026 To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 86107.000000 0 FOR 86107.000000 FOR Disc Medicine, Inc. 254604101 US2546041011 06/18/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 86107.000000 0 FOR 86107.000000 FOR GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2026 Election of Director: Katherine Stueland DIRECTOR ELECTIONS ISSUER 92816.000000 0 FOR 92816.000000 FOR GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 92816.000000 0 FOR 92816.000000 FOR GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2026 Approval, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 92816.000000 0 FOR 92816.000000 FOR GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2026 Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 92816.000000 0 ONE YEAR 92816.000000 FOR Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Alexis Borisy DIRECTOR ELECTIONS ISSUER 11592.000000 0 WITHHOLD 11592.000000 AGAINST Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Mark A. Goldsmith, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 11592.000000 0 FOR 11592.000000 FOR Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 11592.000000 0 FOR 11592.000000 FOR Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 11592.000000 0 FOR 11592.000000 FOR ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Saqib Islam, J.D. DIRECTOR ELECTIONS ISSUER 1783628.000000 0 FOR 1783628.000000 FOR ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Phillip Schneider DIRECTOR ELECTIONS ISSUER 1783628.000000 0 WITHHOLD 1783628.000000 AGAINST ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Laura Shawver, Ph.D. DIRECTOR ELECTIONS ISSUER 1783628.000000 0 FOR 1783628.000000 FOR ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1783628.000000 0 FOR 1783628.000000 FOR ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1783628.000000 0 AGAINST 1783628.000000 AGAINST ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1783628.000000 0 ONE YEAR 1783628.000000 FOR Lucid Diagnostics Inc. 54948X109 US54948X1090 06/24/2026 Election of Class B Directors: James L. Cox, M.D. DIRECTOR ELECTIONS ISSUER 3514366.000000 0 WITHHOLD 3514366.000000 AGAINST Lucid Diagnostics Inc. 54948X109 US54948X1090 06/24/2026 Election of Class B Directors: John R. Palumbo DIRECTOR ELECTIONS ISSUER 3514366.000000 0 WITHHOLD 3514366.000000 AGAINST Lucid Diagnostics Inc. 54948X109 US54948X1090 06/24/2026 Election of Class B Directors: Ronald M. Sparks DIRECTOR ELECTIONS ISSUER 3514366.000000 0 WITHHOLD 3514366.000000 AGAINST Lucid Diagnostics Inc. 54948X109 US54948X1090 06/24/2026 Approval of an amendment to the Certificate of Incorporation to increase the total number of shares of common stock the Company is authorized to issue by 100,000,000 shares, from 300,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 3514366.000000 0 FOR 3514366.000000 FOR Lucid Diagnostics Inc. 54948X109 US54948X1090 06/24/2026 Ratification of the appointment of the independent registered certified public accounting firm. AUDIT-RELATED ISSUER 3514366.000000 0 FOR 3514366.000000 FOR